Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin (Q38081288)

28 August 2017

title

Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin (English)

1 reference

28 August 2017

F R Mooi

1 reference

28 August 2017

N A T Van Der Maas

series ordinal

1 reference

28 August 2017

H E De Melker

series ordinal

1 reference

28 August 2017

publication date

13 February 2013

1 reference

Epidemiology and Infection

28 August 2017

published in

1 reference

28 August 2017

volume

142

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

685-694

1 reference

Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Estimating the duration of pertussis immunity using epidemiological signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Impact of routine vaccination with a pertussis toxoid vaccine in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

The case for maternal vaccination against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Improving pertussis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Small mutations in Bordetella pertussis are associated with selective sweeps

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Comparative genomics of prevaccination and modern Bordetella pertussis strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Factors contributing to pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Immunity to the respiratory pathogen Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Pertussis: a matter of immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Strength and tempo of selection revealed in viral gene genealogies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

SNP-based typing: a useful tool to study Bordetella pertussis populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Population diversity among Bordetella pertussis isolates, United States, 1935-2009

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Pertussis disease burden in the household: how to protect young infants

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Acellular vaccines for preventing whooping cough in children

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Insight into Evolution of Bordetella pertussis from Comparative Genomic Analysis: Evidence of Vaccine-Driven Selection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Association of Bordetella pertussis with host immune cells in the mouse lung

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Bordetella parapertussis isolates not expressing pertactin circulating in France

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

Is leukocytosis a predictor of mortality in severe pertussis infection?

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000071

7 January 2021

10.1017/S0950268813000071

Identifiers

DOI

1 reference

28 August 2017

1 reference